about
Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland.Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter studySpoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.Synthesis, structure, and antimicrobial activity of heterocyclic phenylsulfonyl- and 4-aminophenylsulfonyl-carboximidamides.Synthesis, structure, and biological activity of novel heterocyclic sulfonyl-carboximidamides.Synthesis and biological activity of novel 3-heteroaryl-2H-pyrido[4,3-e][1,2,4]thiadiazine and 3-heteroaryl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxidesIntracardiac tuberculomas caused by Mycobacterium tuberculosis in a dog.Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.Experimental inoculation of BFDV-positive budgerigars (Melopsittacus undulatus) with two Mycobacterium avium subsp. avium isolates.A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.What factors may influence epidemiological situation of tuberculosis in Poland and in the world?Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety.Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides.Leprosy - one of the many forgotten tropical diseases.The incidence of tuberculosis transmission among family members and outside households.Fungal infection of cystic fibrosis patients - single center experience.Synthesis, characterization, and tuberculostatic activity of novel 2-(4-nitrobenzoyl)hydrazinecarbodithioic acid derivatives.Synthesis, structure, and tuberculostatic activity of dimethyl benzoylcarbonohydrazonodithioates.Drug Resistance and Population Structure of Mycobacterium tuberculosis Beijing Strains Isolated in Poland.Tuberculosis in Antelopes in a Zoo in Poland--Problem of Public Health.Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.Antimicrobial and anti-biofilm activity of thiourea derivatives incorporating a 2-aminothiazole scaffold.From Latent Tuberculosis Infection to Tuberculosis. News in Diagnostics (QuantiFERON-Plus).Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants.Bovine tuberculosis in a wild boar (Sus scrofa) in PolandCharacterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains[Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations]Synthesis and Antimicrobial Activity of 4-Chloro-3-Nitrophenylthiourea Derivatives Targeting Bacterial Type II TopoisomerasesCharacterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and GermanyNontuberculous mycobacterial lung disease in a patient with COPD and bronchiectasis, with radiological signs of lung tumor[Microbiological diagnostics in the patients with cystic fibrosis]
P50
Q33769021-5E13D9C9-9B24-4C3C-8E82-A938430F989BQ34420149-958C93BC-40E8-4020-BC2A-10F0DCA0670AQ34489401-A27B0F65-98BD-4A9C-9BAE-26A1F5DA369BQ35544538-ECAA363D-7F8E-4899-BDBD-B60E9DF8A4BFQ35828125-56D1B32A-8EC1-4CF1-8CBB-A5A37407B480Q35828129-6A6B3262-4952-4859-BBC5-6585FBC38F10Q35828880-86EB0116-A92A-4188-B7AE-77A1EEA41CCDQ36052136-26C86C8D-8254-4C8F-96CA-B7AEAD879AE2Q37411216-66D9EA3C-0107-4745-9624-98F6E63F6DA9Q37677230-AF724659-7941-4348-B437-4125C8C19FEEQ38231137-BE5B83CF-EDD5-4052-B468-10B80A567360Q38847688-1649B798-1832-43EE-9D75-153F43E3F782Q38859144-8326F0B0-1F52-4CF0-B3EF-96918179A9F5Q38896671-5B06112D-B416-4671-883F-633637BC646CQ38933436-02681281-565B-443E-A7F3-7B319C828C6AQ38937356-24FE208A-A291-4F09-B15C-772C2965C0E8Q39634817-3E99E4AD-90C7-4066-B891-0F57718F5C77Q40526491-E36D8F5F-852D-44E2-818E-AC95BB04DC48Q40654499-0D4127E7-EE85-49F6-BD5B-C7D8DC8F5BD3Q41269019-2B8F4E24-5B49-4470-9A80-46113D019C6AQ41269321-E01D6A6F-7274-4A78-9DE5-AADC06F0B4B5Q41575389-2443D0D2-73DA-408F-9A3F-D5F55DA82AD7Q41575394-D10095B8-06D1-4F68-82EC-15AD39950B73Q41691172-D2682C50-10C4-4650-87BF-2DADA391A067Q41824901-AA06954B-D9D0-4594-BD91-7B41325475B9Q42155942-B3B6139E-351C-4027-B18A-84B059F6DE38Q47717739-489D3729-89B2-47DF-983A-9115642E8B09Q48002496-2962F60A-CDE2-43BA-ADC5-BD17591D498BQ48225283-17F44DBB-AD02-4BE2-9465-14C440145135Q52565953-68B4A6A3-4FC0-4E5C-BE8F-3171AD0C7F23Q53824364-F3F1FA0F-CDB0-472B-B8BB-72A78EA94D3DQ53835426-392AE9AF-CFA2-40A6-A9AD-6FCAC91CF1AEQ54268462-3DB27110-0ED9-4653-AF6A-F614D116826DQ57096089-E61D8174-6C85-4C4E-9D24-01B957834E1AQ63960610-765B7E72-B445-4B3D-AFE3-085B99BF1EB9Q87037146-25D994C4-349E-4548-90E0-5BE94B2E5DB0Q87147839-48882DBC-733B-4DEF-8EFB-5F02EF10E7B1Q87524178-E2A7E49F-68E9-48BC-822F-2F3F4FC427FCQ87910582-B122326A-4034-4C2B-B431-A62D006F135AQ88153119-D1A65ED8-B16C-4E8D-A9EE-2D9A8560A28A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ewa Augustynowicz-Kopec
@en
Ewa Augustynowicz-Kopec
@nl
type
label
Ewa Augustynowicz-Kopec
@en
Ewa Augustynowicz-Kopec
@nl
prefLabel
Ewa Augustynowicz-Kopec
@en
Ewa Augustynowicz-Kopec
@nl
P31
P496
0000-0001-6162-8748